Search research articles
Contact Us
Filters
Showing results (501-510 of 563) with videos related to
Page
of 57
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 15, 2023
Comparing Accuracy of Helicobacter pylori Identification Using Traditional Hematoxylin and Eosin-Stained Glass Slides With Digital Whole Slide Imaging
Wei Chen, Jennifer Ziebell, Vidya Arole, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 13, 2019
Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers
Luke K Genutis, Jerneja Tomsic, Ralf A Bundschuh, et al.
JCI Insight
|
November 16, 2018
Spatial and phenotypic immune profiling of metastatic colon cancer
Jenny Lazarus, Tomasz Maj, J Joshua Smith, et al.
JAMA Oncology
|
March 30, 2018
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer
Heather Hampel, Rachel Pearlman, Mallory Beightol, et al.
Cancer Research
|
May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang, Michael D Green, Xueting Lang, et al.
Biorxiv : the Preprint Server for Biology
|
January 31, 2024
WITHDRAWN: Oncogenic KRAS <sup>G12D</sup> extrinsically induces an immunosuppressive microenvironment in lung adenocarcinoma
Emily Lasse-Opsahl, Rachael Baliira, Ivana Barravecchia, et al.
Archives of Pathology & Laboratory Medicine
|
January 17, 2018
Colorectal Carcinomas With Isolated Loss of PMS2 Staining by Immunohistochemistry
Lindsay Alpert, Reetesh K Pai, Amitabh Srivastava, et al.
Iscience
|
August 9, 2023
Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression
Debasmita Mukherjee, Srija Chakraborty, Lena Bercz, et al.
JAMA Oncology
|
July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial
Matthew H G Katz, Qian Shi, Jeff Meyers, et al.
JCI Insight
|
January 9, 2025
KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling
Emily L Lasse-Opsahl, Ivana Barravecchia, Elyse McLintock, et al.
Page
of 57
Search research articles
Search
Showing results (501-510 of 563) with videos related to
Sort By:
Page
of 57
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 15, 2023
Comparing Accuracy of Helicobacter pylori Identification Using Traditional Hematoxylin and Eosin-Stained Glass Slides With Digital Whole Slide Imaging
Wei Chen, Jennifer Ziebell, Vidya Arole, et al.
Thyroid : Official Journal of the American Thyroid Association
|
February 13, 2019
Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers
Luke K Genutis, Jerneja Tomsic, Ralf A Bundschuh, et al.
JCI Insight
|
November 16, 2018
Spatial and phenotypic immune profiling of metastatic colon cancer
Jenny Lazarus, Tomasz Maj, J Joshua Smith, et al.
JAMA Oncology
|
March 30, 2018
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer
Heather Hampel, Rachel Pearlman, Mallory Beightol, et al.
Cancer Research
|
May 19, 2019
Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy
Qiang Zhang, Michael D Green, Xueting Lang, et al.
Biorxiv : the Preprint Server for Biology
|
January 31, 2024
WITHDRAWN: Oncogenic KRAS <sup>G12D</sup> extrinsically induces an immunosuppressive microenvironment in lung adenocarcinoma
Emily Lasse-Opsahl, Rachael Baliira, Ivana Barravecchia, et al.
Archives of Pathology & Laboratory Medicine
|
January 17, 2018
Colorectal Carcinomas With Isolated Loss of PMS2 Staining by Immunohistochemistry
Lindsay Alpert, Reetesh K Pai, Amitabh Srivastava, et al.
Iscience
|
August 9, 2023
Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progression
Debasmita Mukherjee, Srija Chakraborty, Lena Bercz, et al.
JAMA Oncology
|
July 14, 2022
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial
Matthew H G Katz, Qian Shi, Jeff Meyers, et al.
JCI Insight
|
January 9, 2025
KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling
Emily L Lasse-Opsahl, Ivana Barravecchia, Elyse McLintock, et al.
Page
of 57